March 10, 2024

The world of medicine is witnessing a paradigm shift in the battle against antibiotic resistance. Recent breakthroughs have unveiled innovative strategies to combat this global health threat, offering a glimmer of hope in the face of rising superbugs. A team of scientists from Imperial College London has discovered a novel approach to impair antibiotic-resistant bacteria. […]

In a significant development on December 22, 2022, the U.S. Food and Drug Administration (FDA) approved a new antiretroviral medication, Sunlenca (lenacapavir), for adult patients living with human immunodeficiency virus type 1 (HIV-1). This approval marks an important moment in the evolution of HIV treatment, introducing a novel class of drugs known as capsid inhibitors